
Trident Texofab Ltd Falls to 52-Week Low of Rs 35.55 as Sell-Off Deepens
2026-06-08 09:49:57For the sixth consecutive session, Trident Texofab Ltd has closed lower, culminating in a fresh 52-week low of Rs 35.55 on 8 Jun 2026. This marks a steep 15.5% decline over this losing streak and a staggering 82.57% drop over the past year, sharply underperforming the Sensex's 10.46% fall in the same period.
Read full news article
Trident Texofab Ltd is Rated Strong Sell
2026-06-03 10:11:05Trident Texofab Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 03 June 2026, providing investors with the latest insights into the company’s performance and outlook.
Read full news articleAre Trident Texofab Ltd latest results good or bad?
2026-06-02 19:37:56Trident Texofab Ltd's latest financial results for the quarter ending March 2026 indicate significant operational challenges. The company reported a year-on-year decline in net sales of 12.14%, falling to ₹33.57 crores, despite a sequential recovery of 30.42% from the previous quarter. This decline raises concerns about the company's market position and pricing strategy within the competitive textile sector. Moreover, Trident Texofab experienced a substantial shift into operating losses, with an operating profit margin of -3.25%, contrasting sharply with the positive margin of 3.56% reported in the same quarter last year. This marks the lowest operating profitability in recent quarters, highlighting potential issues with cost management and competitive viability. The net profit for the quarter was reported at a loss of ₹2.01 crores, a stark reversal from a profit of ₹0.51 crores in the prior year. This re...
Read full news article
Trident Texofab Ltd Valuation Shifts Signal Mixed Prospects Amid Market Pressure
2026-06-02 08:05:10Trident Texofab Ltd, a micro-cap player in the Garments & Apparels sector, has experienced a notable shift in its valuation parameters, moving from a very attractive to an attractive rating. Despite this improvement, the company’s stock continues to face significant headwinds, reflected in its recent price decline and a strong sell mojo grade. This article analyses the evolving valuation metrics, compares them with peers and historical benchmarks, and assesses the implications for investors navigating a challenging market environment.
Read full news article
Trident Texofab Q4 FY26: Sharp Loss Erodes Investor Confidence as Stock Plunges
2026-06-01 12:24:56Trident Texofab Ltd., a Surat-based garments and apparels manufacturer, reported a devastating fourth quarter for FY26, posting a net loss of ₹2.01 crores compared to a profit of ₹0.51 crores in the same quarter last year. The micro-cap company with a market capitalisation of ₹65.00 crores has seen its stock price collapse by 79.14% over the past year, with shares trading at ₹41.70 as of June 1, 2026, down 4.66% on the day following the results announcement.
Read full news article
Trident Texofab Ltd Reports Sharp Decline in Quarterly Performance Amid Negative Financial Trend
2026-06-01 11:01:42Trident Texofab Ltd, a micro-cap player in the Garments & Apparels sector, has reported a significant deterioration in its financial performance for the quarter ended March 2026. The company’s financial trend has shifted from flat to negative, with key metrics such as net sales, profit after tax, and operating margins showing marked declines compared to previous quarters and historical averages.
Read full news articleWhen is the next results date for Trident Texofab Ltd?
2026-05-25 23:16:16The next results date for Trident Texofab Ltd is scheduled for 28 May 2026....
Read full news article
Trident Texofab Ltd Downgraded to Sell Amid Mixed Technicals and Weak Fundamentals
2026-05-19 08:58:29Trident Texofab Ltd’s investment rating has been upgraded from Strong Sell to Sell as of 18 May 2026, reflecting a nuanced shift in its technical outlook amid persistent fundamental challenges. While the company’s financial performance remains subdued, improvements in technical indicators have prompted a reassessment of its near-term prospects, signalling a cautiously less bearish stance for investors.
Read full news articleCompliances-Reg.24(A)-Annual Secretarial Compliance
01-Jun-2026 | Source : BSEIn compliance with the Regulation 24A of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 read with relevant Circular(s) issued by SEBI in this regard please find enclosed herewith the Annual Secretarial Compliance Report for Financial Year ended March 31 2026 issued by Amareliya & Associates Practising Company Secretary.
Announcement under Regulation 30 (LODR)-Newspaper Publication
01-Jun-2026 | Source : BSEPursuant to Regulation 30 read with Schedule III Part A Para A and Regulation 47 of SEBI Listing Regulations we hereby enclose copies of newspaper advertisement published regarding extract of the Audited Financial Results for the quarter and Year ended March 31 2026.
Result- Financial Result For Quarter And Year Ended 31.03.2026
30-May-2026 | Source : BSEFinancial Result for Quarter and Year ended 31.03.2026
Corporate Actions
No Upcoming Board Meetings
Trident Texofab Ltd has declared 10% dividend, ex-date: 18 Jul 19
No Splits history available
Trident Texofab Ltd has announced 14:10 bonus issue, ex-date: 11 Aug 20
No Rights history available







